Follow
Zsolt Nagy
Zsolt Nagy
Verified email at med.semmelweis-univ.hu
Title
Cited by
Cited by
Year
Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma
MV Mateos, MA Dimopoulos, M Cavo, K Suzuki, A Jakubowiak, S Knop, ...
New England Journal of Medicine 378 (6), 518-528, 2018
9582018
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a …
M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ...
The Lancet 394 (10214), 2096-2107, 2019
610*2019
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
G Salles, J Duell, EG Barca, O Tournilhac, W Jurczak, AM Liberati, Z Nagy, ...
The Lancet Oncology 21 (7), 978-988, 2020
4562020
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
MV Mateos, M Cavo, J Blade, MA Dimopoulos, K Suzuki, A Jakubowiak, ...
The Lancet 395 (10218), 132-141, 2020
3902020
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
IW Flinn, P Hillmen, M Montillo, Z Nagy, Á Illés, G Etienne, J Delgado, ...
Blood, The Journal of the American Society of Hematology 132 (23), 2446-2455, 2018
3392018
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ...
The Lancet 397 (10292), 2361-2371, 2021
2432021
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...
The Lancet 393 (10168), 253-264, 2019
2412019
Effect of gypsum on proliferation and differentiation of MC3T3-E1 mouse osteoblastic cells
Á Lazáry, B Balla, JP Kósa, K Bácsi, Z Nagy, I Takács, PP Varga, G Speer, ...
Biomaterials 28 (3), 393-399, 2007
1342007
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
J Duell, KJ Maddocks, E González-Barca, W Jurczak, AM Liberati, ...
haematologica 106 (9), 2417, 2021
1302021
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria
A Röth, J Nishimura, Z Nagy, J Gaŕl-Weisinger, J Panse, SS Yoon, ...
Blood, The Journal of the American Society of Hematology 135 (12), 912-920, 2020
1032020
Prävention der Kortikosteroid-induzierten Osteoporose durch Alfacalcidol
P Lakatos, Z Nagy, L Kiss, C Horvath, I Takacs, J Foldes, G Speer, ...
Zeitschrift für Rheumatologie 59, I48-I52, 2000
952000
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic …
M Spina, Z Nagy, JM Ribera, M Federico, I Aurer, K Jordan, G Borsaru, ...
Annals of oncology 26 (10), 2155-2161, 2015
822015
Comparing the trueness of seven intraoral scanners and a physical impression on dentate human maxilla by a novel method
Z Nagy, B Simon, A Mennito, Z Evans, W Renne, J Vág
BMC Oral Health 20, 1-10, 2020
772020
Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism
P Lakatos, J Foldes, Z Nagy, I Takacs, G Speer, C Horvath, S Mohan, ...
Thyroid 10 (5), 417-423, 2000
702000
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ...
The Lancet 401 (10373), 269-280, 2023
662023
Rho and Rho Kinase Are Involved in Parathyroid Hormone‐Stimulated Protein Kinase C α Translocation and IL‐6 Promoter Activity in Osteoblastic Cells
JM Radeff, Z Nagy, PH Stern
Journal of bone and mineral research 19 (11), 1882-1891, 2004
582004
Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women
B Balla, JP Kósa, J Kiss, A Borsy, J Podani, I Takács, A Lazáry, Z Nagy, ...
Calcified tissue international 82, 12-26, 2008
542008
Hungarian consensus regarding the role of vitamin D in the prevention and treatment of diseases
I Takács, I Benkő, E Toldy, N Wikonkál, L Szekeres, E Bodolay, E Kiss, ...
Orvosi hetilap 153, 5-26, 2012
522012
CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells
JP Kósa, P Horváth, J Wölfling, D Kovács, B Balla, P Mátyus, E Horváth, ...
World journal of gastroenterology: WJG 19 (17), 2621, 2013
432013
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
FH Schjesvold, MA Dimopoulos, S Delimpasi, P Robak, D Coriu, ...
The Lancet Haematology 9 (2), e98-e110, 2022
422022
The system can't perform the operation now. Try again later.
Articles 1–20